Skip to main content

Thymidylate Synthase Inhibition Induces P53 Dependent and Independent Cell Death

  • Chapter
Purine and Pyrimidine Metabolism in Man X

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Takemura, Y., and Jackman, A.L., 1997, Folate-based thymidylate synthase inhibitors in cancer chemotherapy. Cancer Drugs 8: 3–16

    CAS  Google Scholar 

  2. Peters, G.J., and Ackland, S.P., 1996, New antimetabolites in preclinical and clinical development. Exp. Opin. Invest. Drugs 5: 637–679

    CAS  Google Scholar 

  3. Lane, D.P., 1992, P53, guardian of the genome. Nature 358: 15–16

    Article  CAS  PubMed  Google Scholar 

  4. Korsmeyer, S.J., 1995, Regulators of cell death. Trends Genet. 11: 101–105

    Article  CAS  PubMed  Google Scholar 

  5. Nagata, S., 1997, Apoptosis by death factor. Cell 88: 355–365

    Article  CAS  PubMed  Google Scholar 

  6. Van der Wilt, C.L., Kuiper, C.M., and Peters, G.J., 1999, Combination studies of antifolates with 5-fluorouracil in colon cancer cell lines. Oncol Res 11: 383–391

    PubMed  Google Scholar 

  7. Peters, G.J., Van Triest, B., Backus, H.H.J, Kuiper, C.M., Van der Wilt, C.L., and Pinedo, H.M., 2000, Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor Tomudex. Eur. J. Cancer, 36: 916–924.

    Article  CAS  PubMed  Google Scholar 

  8. Chu, E., and Allegra, C.J., 1995, The role of thymidylate synthase as an RNA binding protein. BioEssays 18: 191–198

    Google Scholar 

  9. Kitchens, M.E., Forsthoefel, A.M., Barbour, K.W., Spencer, H.T., and Berger, F.G., 1999, Mechanisms of acquired resistance to thymidylate synthase inhibitors: the role of enzyme stability. Mol Pharmacol 56: 1063–1070

    CAS  PubMed  Google Scholar 

  10. Miyashita, T., Krajewski, M., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B., and Reed, J.C., 1994, Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9: 1799–1805

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Backus, H.H. et al. (2002). Thymidylate Synthase Inhibition Induces P53 Dependent and Independent Cell Death. In: Zoref-Shani, E., Sperling, O. (eds) Purine and Pyrimidine Metabolism in Man X. Advances in Experimental Medicine and Biology, vol 486. Springer, Boston, MA. https://doi.org/10.1007/0-306-46843-3_59

Download citation

  • DOI: https://doi.org/10.1007/0-306-46843-3_59

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-46515-4

  • Online ISBN: 978-0-306-46843-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics